News

Transcept Pharmaceuticals submitted a revised proposal for the resubmission of the Intermezzo New Drug Application (NDA) to the FDA for evaluation and comment. The FDA stated in the

Under the collaboration, the organisations intend to initially develop and manufacture vaccines for flu, dengue fever and West Nile virus. Phillip Frost, chairman and CEO of Opko, said:

By displaying the current condition of the cerebral tissue directly in the angio suite, syngo Neuro Parenchymal Blood Volume, Interventional Suite (PBV IR) assists in the accurate guidance

Parascript AccuDetect is designed to contribute to better cancer detection and lower patient recalls through employment of complementary algorithms and two major, proprietary technology approaches. The first approach

PPD is expecting that the offices will strengthen its full range of drug discovery and development services and continue to position it to capitalise on the growth of

The MAA was withdrawn following communication from the Committee for Medicinal Products for Human Use (CHMP) of the EMA citing a major objection. The major objection noted that

The consolidation of DSP’s two North American businesses serves to solidify DSP’s North American operations into one combined center of excellence. The unification of DSPA and Sepracor brings

Hematide, a synthetic, peptide-based erythropoiesis-stimulating agent (ESA), is designed to act on the erythropoietin receptors and stimulate the production of red blood cells by dosing once every four

The study investigated the use of GM-CSF (granulocyte/macrophage colony-stimulating factor) as an adjuvant with the DNA prime for the GeoVax DNA/MVA vaccine for prevention of HIV/AIDS. The National